Advances in the application of biochemical tests to diseases of the liver and biliary tract: their role in diagnosis, prognosis, and the elucidation of pathogenetic mechanisms (Q39662146)

From Wikidata

Jump to navigation Jump to search

scientific article published on April 1987

Language	Label	Description	Also known as
English	Advances in the application of biochemical tests to diseases of the liver and biliary tract: their role in diagnosis, prognosis, and the elucidation of pathogenetic mechanisms	scientific article published on April 1987

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

13 September 2017

1 reference

Europe PubMed Central

Advances in the application of biochemical tests to diseases of the liver and biliary tract: their role in diagnosis, prognosis, and the elucidation of pathogenetic mechanisms (English)

1 reference

Europe PubMed Central

PubMed publication ID

13 September 2017

0 references

author name string

Goldberg DM

1

1 reference

Europe PubMed Central

PubMed publication ID

13 September 2017

Brown D

2

1 reference

Europe PubMed Central

PubMed publication ID

13 September 2017

publication date

1 April 1987

1 reference

Europe PubMed Central

PubMed publication ID

13 September 2017

Clinical Biochemistry

1 reference

Europe PubMed Central

PubMed publication ID

13 September 2017

20

1 reference

Europe PubMed Central

PubMed publication ID

13 September 2017

2

1 reference

Europe PubMed Central

PubMed publication ID

13 September 2017

127-148

1 reference

Europe PubMed Central

PubMed publication ID

13 September 2017

Normal liver function. A basis for understanding hepatic disease

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9120%2887%2980111-X

7 January 2021

Laboratory tests and diagnostic procedures in evaluation of liver disease

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9120%2887%2980111-X

7 January 2021

Discriminant function analysis applied to laboratory tests in patients with hepatobiliary disease

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9120%2887%2980111-X

7 January 2021

Bile Acid Metabolism

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9120%2887%2980111-X

7 January 2021

Serum bile acids in hepatobiliary disease

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9120%2887%2980111-X

7 January 2021

Serum bile acid analysis

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9120%2887%2980111-X

7 January 2021

Serum bile acid patterns determined by an enzymatic method and high-performance liquid chromatography in young infants with cholestasis

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9120%2887%2980111-X

7 January 2021

Differential diagnostic value in hepatobiliary disease of serum conjugated bile acid concentrations and some routine liver tests assessed by discriminant analysis

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9120%2887%2980111-X

7 January 2021

Predictive value of the concentration in serum of total 3 alpha-hydroxy bile acids in the diagnosis of hepatobiliary disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9120%2887%2980111-X

7 January 2021

The aminopyrine demethylation breath test and the serum bile acid level: nominated but not yet elected to join the common liver tests.

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9120%2887%2980111-X

7 January 2021

Diagnostic effectiveness of serum bile acids in liver diseases as evaluated by multivariate statistical methods.

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9120%2887%2980111-X

7 January 2021

Serum bile acids in the diagnosis of hepatobiliary disease

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9120%2887%2980111-X

7 January 2021

A correlation of serum bile acid levels with conventional biochemical parameters in the assessment of hepatobiliary dysfunctions

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9120%2887%2980111-X

7 January 2021

Evaluation of the diagnostic value of serum bile acid in the detection and functional assessment of liver diseases.

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9120%2887%2980111-X

7 January 2021

Fasting serum bile acids in liver disease. A comparison with histological features.

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9120%2887%2980111-X

7 January 2021

Diagnostic Values of Fasting and Postprandial Concentrations in Serum of 3α-Hydroxy-Bile Acids and Gamma-Glutamyl Transferase in Hepatobiliary Disease

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9120%2887%2980111-X

7 January 2021

Postprandial changes in serum concentrations of individual bile salts in normal subjects and patients with acute viral hepatitis.

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9120%2887%2980111-X

7 January 2021

Serum bile acids and alanine aminotransferase concentrations. Comparison of efficacy as indirect means of identifying carriers of non-A, non-B hepatitis agents and of onset, severity, and duration of posttransfusion non-A, non-B hepatitis in recipie

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9120%2887%2980111-X

7 January 2021

Assessment of liver function using fasting bile salt concentrations in psoriasis prior to and during methotrexate therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9120%2887%2980111-X

7 January 2021

Serum bile acids in Gilbert's syndrome before and after reduced caloric intake.

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9120%2887%2980111-X

7 January 2021

Clinical value of serum bile acid levels in chronic hepatitis

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9120%2887%2980111-X

7 January 2021

The aminopyrine breath test and serum bile acids reflect histologic severity in chronic hepatitis.

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9120%2887%2980111-X

7 January 2021

Serum bile acid levels in children with chronic persistent hepatitis and chronic aggressive hepatitis.

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9120%2887%2980111-X

7 January 2021

Endogenous bile acid tolerance test for liver function.

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9120%2887%2980111-X

7 January 2021

Serum cholic and chenodeoxycholic acid conjugates and standard liver function tests in various morphological stages of alcoholic liver disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9120%2887%2980111-X

7 January 2021

Total serum bile acids, gamma-glutamyl transferase, prealbumin, and tyrosine: sensitive serum markers of hepatic dysfunction in alcoholic liver cirrhosis.

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9120%2887%2980111-X

7 January 2021

Total fasting serum bile acids and β-hexosaminidase in alcoholic liver disease

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9120%2887%2980111-X

7 January 2021

Clinical value of bile salt tests in anicteric liver disease

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9120%2887%2980111-X

7 January 2021

Evaluation of postprandial serum bile acid response as a test of hepatic function

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9120%2887%2980111-X

7 January 2021

Prognostic significance of serum bile acids in cirrhosis

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9120%2887%2980111-X

7 January 2021

The diagnostic value of fasting individual serum bile acids in anicteric alcoholic liver disease: relation to liver morphology.

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9120%2887%2980111-X

7 January 2021

Hepatic uptake of bile acids in man. Fasting and postprandial concentrations of individual bile acids in portal venous and systemic blood serum

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9120%2887%2980111-X

7 January 2021

Dynamics of the enterohepatic circulation of bile acids. Postprandial serum concentrations of conjugates of cholic acid in health, cholecystectomized patients, and patients with bile acid malabsorption

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9120%2887%2980111-X

7 January 2021

Postprandial serum bile acids in healthy man. Evidence for differences in absorptive pattern between individual bile acids

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9120%2887%2980111-X

7 January 2021

Fasting and postprandial serum bile acids as a screening test for hepatocellular disease

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9120%2887%2980111-X

7 January 2021

The patterns of glycine and taurine conjugates of bile acids in serum in hepatobiliary disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9120%2887%2980111-X

7 January 2021

Serum bile acids and their conjugates in breast-fed infants with prolonged jaundice

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9120%2887%2980111-X

7 January 2021

Bile acids and their sulphated and glucuronidated derivatives in bile, plasma, and urine of children with intrahepatic cholestasis: effects of phenobarbital treatment

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9120%2887%2980111-X

7 January 2021

Biliary and urinary excretion of sulfated, glucuronidated and tetrahydroxylated bile acids in cirrhotic patients

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9120%2887%2980111-X

7 January 2021

Serum concentrations of bile acid glucuronides in hepatobiliary diseases

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9120%2887%2980111-X

7 January 2021

Unusual serum bile acid pattern in children with the syndrome of hepatic ductular hypoplasia.

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9120%2887%2980111-X

7 January 2021

Unusual trihydroxylated bile acids in urine of patients with liver cirrhosis

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9120%2887%2980111-X

7 January 2021

Assessment of the plasma disappearance of cholyl'l14C-glycine as a test of hepatocellular disease

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9120%2887%2980111-X

7 January 2021

Direct Measurement of Hepatic Extraction of Bile Acids in Subjects with and without Liver Disease

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9120%2887%2980111-X

7 January 2021

Bile acid metabolism in cirrhosis. VIII. Quantitative evaluation of bile acid synthesis from [7 beta-3H]7 alpha-hydroxycholesterol and [G-3H]26-hydroxycholesterol.

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9120%2887%2980111-X

7 January 2021

Cholic acid conjugation test and quantitative liver function in acute liver failure

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9120%2887%2980111-X

7 January 2021

Serum Bile Acids in Primary Biliary Cirrhosis

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9120%2887%2980111-X

7 January 2021

Drugs as indicators of hepatic function.

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9120%2887%2980111-X

7 January 2021

Cholestasis and hepatic drug metabolism. Comparison of metabolic clearance rate of antipyrine in patients with intrahepatic or extrahepatic cholestasis

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9120%2887%2980111-X

7 January 2021

Output of 14CO2 in breath after oral administration of (14C-methyl) aminopyrine in hepatitis, cirrhosis and hepatic bilharziasis: its relationship to aminopyrine pharmacokinetics

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9120%2887%2980111-X

7 January 2021

A [14C]phenacetin breath test to measure hepatic function in man

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9120%2887%2980111-X

7 January 2021

Comparison of the phenacetin and aminopyrine breath tests: effect of liver disease, inducers and cobaltous chloride

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9120%2887%2980111-X

7 January 2021

Antipyrine clearance per unit volume liver: an assessment of hepatic function in chronic liver disease

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9120%2887%2980111-X

7 January 2021

Antipyrine clearance and metabolite formation in patients with alcoholic cirrhosis

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9120%2887%2980111-X

7 January 2021

Effect of age and sex on the N-demethylation rate of 14C-aminopyrine, studied by the breath test

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9120%2887%2980111-X

7 January 2021

Hepatic antipyrine metabolism in malnourished patients: influence of the type of malnutrition and course after nutritional rehabilitation

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9120%2887%2980111-X

7 January 2021

Antipyrine clearance and metabolite formation: the influence of liver volume and smoking

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9120%2887%2980111-X

7 January 2021

The relationship between conventional liver tests, quantitative function tests, and histopathology in cirrhosis

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9120%2887%2980111-X

7 January 2021

Antipyrine elimination as a dynamic test of hepatic functional integrity in obstructive jaundice

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9120%2887%2980111-X

7 January 2021

Antipyrine elimination in patients with obstructive jaundice: a predictor of outcome

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9120%2887%2980111-X

7 January 2021

Assessment of the (14C) aminopyrine breath test in liver disease

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9120%2887%2980111-X

7 January 2021

The detection of minimal alcoholic liver disease by three methods

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9120%2887%2980111-X

7 January 2021

Aminopyrine breath test. Prospective comparison with liver histology and liver chemistry tests following jejunoileal bypass performed for refractory obesity

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9120%2887%2980111-X

7 January 2021

[14C]Aminopyrine breath test in chronic liver disease: preliminary diagnostic implications

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9120%2887%2980111-X

7 January 2021

Comparison of different methods expressing results of the aminopyrine breath test

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9120%2887%2980111-X

7 January 2021

Studies in alcoholic liver disease in Britain. I. Clinical and pathological patterns related to natural history

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9120%2887%2980111-X

7 January 2021

Duration of survival in patients with Laennec's cirrhosis. Influence of alcohol withdrawal, and possible effects of recent changes in general management of the disease

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9120%2887%2980111-X

7 January 2021

Aminopyrine breath test in alcoholic liver disease and in patients on enzyme-inducing drugs

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9120%2887%2980111-X

7 January 2021

Quantitative Assessment of Hepatic Function by Breath Analysis after Oral Administration of [^14C]aminopyrine

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9120%2887%2980111-X

7 January 2021

Aminopyrine breath test predicts surgical risk for patients with liver disease

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9120%2887%2980111-X

7 January 2021

[14C]aminopyrine breath analysis and conventional biochemical tests as predictors of survival in cirrhosis

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9120%2887%2980111-X

7 January 2021

Predicting outcome of paracetamol poisoning by use 14C-aminopyrine breath test

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9120%2887%2980111-X

7 January 2021

[1-14C]Ethanol breath test in alcoholic liver disease

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9120%2887%2980111-X

7 January 2021

METABOLISM OF IODINE-131--LABELED THYROXINE-BINDING PREALBUMIN IN MAN

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9120%2887%2980111-X

7 January 2021

Serum "prealbumin" as an index of liver function in human hepatobiliary disease

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9120%2887%2980111-X

7 January 2021

Association between plasma high density lipoprotein cholesterol and antipyrine metabolism in alcoholics

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9120%2887%2980111-X

7 January 2021

Serum apolipoprotein A-II, a biochemical indicator of alcohol abuse

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9120%2887%2980111-X

7 January 2021

Biochemical and haematological response to alcohol intake

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9120%2887%2980111-X

7 January 2021

Alcohol: high density lipoproteins, apolipoproteins

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9120%2887%2980111-X

7 January 2021

Effects of alcohol consumption on serum lipoprotein-lipid and apolipoprotein concentrations. Results from an intervention study in healthy subjects

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9120%2887%2980111-X

7 January 2021

Effect of alcohol intake on high and low density lipoprotein metabolism in healthy volunteers

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9120%2887%2980111-X

7 January 2021

Apolipoproteins A-I, A-II and B in chronic active hepatitis and in liver cirrhotic patients

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9120%2887%2980111-X

7 January 2021

High serum levels of secretory IgA in liver disease: possible liver origin of the circulating secretory component

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9120%2887%2980111-X

7 January 2021

Serum and intestinal secretory IgA in alcoholic cirrhosis of the liver

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9120%2887%2980111-X

7 January 2021

Serum secretory component: a potential marker of biliary obstruction

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9120%2887%2980111-X

7 January 2021

Serum Immunoglobulin Concentrations and Autoantibody Titers in Diseases of the Liver and Biliary Tree

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9120%2887%2980111-X

7 January 2021

IgA antibody to lipid A in alcoholic liver disease

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9120%2887%2980111-X

7 January 2021

Serum IgM in primary biliary cirrhosis

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9120%2887%2980111-X

7 January 2021

Monomeric (7S) IgM in primary biliary cirrhosis

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9120%2887%2980111-X

7 January 2021

Serum prealbumin, transferrin and immunoglobulins in fatty liver, alcoholic cirrhosis and primary biliary cirrhosis

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9120%2887%2980111-X

7 January 2021

Serological and histological diagnosis of primary biliary cirrhosis

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9120%2887%2980111-X

7 January 2021

Mitochondrial Antibody in Primary Biliary Cirrhosis and Other Diseases

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9120%2887%2980111-X

7 January 2021

Is mitochondrial antibody diagnostic of primary biliary cirrhosis?

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9120%2887%2980111-X

7 January 2021

Frequency and significance of antimitochondrial antibodies in severe chronic active hepatitis

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9120%2887%2980111-X

7 January 2021

What does the antimitochondrial antibody mean?

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9120%2887%2980111-X

7 January 2021

A mitochondrial antigen-antibody system in cholestatic liver disease detected by radioimmunoassay

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9120%2887%2980111-X

7 January 2021

Mitochondrial antibodies in primary biliary cirrhosis: species and nonspecies specific determinants of M2 antigen

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9120%2887%2980111-X

7 January 2021

Hepatic fibrosis. Correlation of biochemical and morphologic investigations

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9120%2887%2980111-X

7 January 2021

The biosynthesis of collagen and its disorders (first of two parts).

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9120%2887%2980111-X

7 January 2021

The biosynthesis of collagen and its disorders (second of two parts).

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9120%2887%2980111-X

7 January 2021

Variation in serum type III procollagen peptide with age in healthy subjects and its comparative value in the assessment of disease activity in children and adults with chronic active hepatitis

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9120%2887%2980111-X

7 January 2021

Biosynthesis of Procollagen

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9120%2887%2980111-X

7 January 2021

The N-terminal propeptide of collagen type III in serum reflects activity and degree of fibrosis in patients with chronic liver disease

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9120%2887%2980111-X

7 January 2021

Aminoterminal procollagen III peptide elevation in alcoholics who are selenium and vitamin E deficient

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9120%2887%2980111-X

7 January 2021

Diagnostic value of serum procollagen peptide measurements in alcoholic liver disease

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9120%2887%2980111-X

7 January 2021

The blue glass and the predictive value of serum amino-terminal propeptide of type III procollagen as a marker of liver fibrosis

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9120%2887%2980111-X

7 January 2021

A radioimmunoassay procedure for type III procollagen: its use in the detection of hepatic fibrosis

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9120%2887%2980111-X

7 January 2021

Evaluation of hepatic fibrosis by serum proline and amino-terminal type III procollagen peptide levels in alcoholic patients

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9120%2887%2980111-X

7 January 2021

Enzymes of collagen synthesis and type III procollagen aminopropeptide in the evaluation of D-penicillamine and medroxyprogesterone treatments of primary biliary cirrhosis

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9120%2887%2980111-X

7 January 2021

Serum procollagen type III peptide as a marker of hepatic fibrogenesis in alcoholic hepatitis

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9120%2887%2980111-X

7 January 2021

Three serum markers of collagen biosynthesis in Nigerians with cirrhosis and various infectious diseases

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9120%2887%2980111-X

7 January 2021

Enzymes of collagen synthesis and type iii procollagen amino-propeptide in serum from nigerians with hepatocellular carcinoma and other malignant diseases

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9120%2887%2980111-X

7 January 2021

Radioimmunoassay for type III procollagen peptide and its application to human liver disease

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9120%2887%2980111-X

7 January 2021

Serum immunoreactive prolyl hydroxylase in liver disease

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9120%2887%2980111-X

7 January 2021

Collagen biosynthesis enzymes in serum and hepatic tissue in liver disease. I. Prolyl hydroxylase

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9120%2887%2980111-X

7 January 2021

Serum concentration of procollagen-III-peptide in comparison with the serum activity of N-acetyl-β-glucosaminidase for diagnosis of the activity of liver fibrosis in patients with chronic active liver diseases

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9120%2887%2980111-X

7 January 2021

Type III procollagen peptide and PZ-peptidase serum levels in pre-cirrhotic liver diseases

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9120%2887%2980111-X

7 January 2021

Long-term follow-up of serum N-terminal propeptide of collagen type III levels in patients with chronic liver disease

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9120%2887%2980111-X

7 January 2021

Activities of prolyl hydroxylase, lysyl hydroxylase, collagen galactosyltransferase and collagen glucosyltransferase in the liver of rats with hepatic injury

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9120%2887%2980111-X

7 January 2021

Hepatic prolyl hydroxylase and collagen synthesis in patients with alcoholic liver disease

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9120%2887%2980111-X

7 January 2021

Hepatic Peptidyl Prolyl Hydroxylase Activity and Liver Fibrosis-A Prospective Study of 94 Infants and Children with Hepatobiliary Disorders

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9120%2887%2980111-X

7 January 2021

Proline-hydroxylase activity in human blood.

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9120%2887%2980111-X

7 January 2021

Increased serum alpha-L-fucosidase and beta-N-acetylglucosaminidase activities in diabetic, cirrhotic and gastric cancer patients

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9120%2887%2980111-X

7 January 2021

Predictive values of serum N-acetyl-beta-D-glucosaminidase for fibrotic liver disorders--correlation with monoamine oxidase activity

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9120%2887%2980111-X

7 January 2021

Type IV collagen and laminin-related antigens in human serum in alcoholic liver disease

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9120%2887%2980111-X

7 January 2021

Radioimmunoassay for human type VI collagen and its application to tissue and body fluids

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9120%2887%2980111-X

7 January 2021

Serum beta 2-microglobulin levels in primary biliary cirrhosis

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9120%2887%2980111-X

7 January 2021

Distribution of fibronectin in plasma and liver in liver diseases

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9120%2887%2980111-X

7 January 2021

Increased concentrations of a transferrin variant after alcohol abuse

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9120%2887%2980111-X

7 January 2021

ENCEPHALOPATHY AND FATTY DEGENERATION OF THE VISCERA. A DISEASE ENTITY IN CHILDHOOD

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9120%2887%2980111-X

7 January 2021

Reye's syndrome: 20 years on.

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9120%2887%2980111-X

7 January 2021

Fatty liver in sudden childhood death. Implications for Reye's syndrome?

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9120%2887%2980111-X

7 January 2021

Reye's syndrome. Salicylate metabolism, viral antibody levels, and other factors in surviving patients and unaffected family members

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9120%2887%2980111-X

7 January 2021

Serum salicylate concentrations in Reye's disease. A study of 130 biopsy-proven cases

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9120%2887%2980111-X

7 January 2021

Reye syndrome in children receiving salicylate therapy for connective tissue disease

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9120%2887%2980111-X

7 January 2021

Grade I Reye's syndrome. A frequent cause of vomiting and liver dysfunction after varicella and upper-respiratory-tract infection

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9120%2887%2980111-X

7 January 2021

Reye syndrome: A metabolic response to an acute mitochondrial insult

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9120%2887%2980111-X

7 January 2021

Amino acid pattern in Reye syndrome: Comparison with clinically similar entities

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9120%2887%2980111-X

7 January 2021

Comparison of cytosolic and mitochondrial hepatic enzyme alterations in Reye's syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9120%2887%2980111-X

7 January 2021

How common is Reye's syndrome?

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9120%2887%2980111-X

7 January 2021

Reye's syndrome: patient serum alters mitochondrial function and morphology in vitro

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9120%2887%2980111-X

7 January 2021

Effect of Reye's syndrome serum on isolated chinchilla liver mitochondria

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9120%2887%2980111-X

7 January 2021

Aetiology of Reye's syndrome.

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9120%2887%2980111-X

7 January 2021

Reye's syndrome in children under three years old.

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9120%2887%2980111-X

7 January 2021

Clinical features and prognosis of Reye's syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9120%2887%2980111-X

7 January 2021

Commentary: The diagnosis of Reye syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9120%2887%2980111-X

7 January 2021

Reye's syndrome. I. Blood ammonia and consideration of the nonhistologic diagnosis

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9120%2887%2980111-X

7 January 2021

Scientific uncertainties in the studies of salicylate use and Reye's syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9120%2887%2980111-X

7 January 2021

Recognition and early management of Reye's syndrome.

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9120%2887%2980111-X

7 January 2021

Grade I Reye's syndrome--outcome and predictors of progression to deeper coma grades

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9120%2887%2980111-X

7 January 2021

The proportion of mitochondrial isoenzyme of aspartate aminotransferase is not elevated in Reye's syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9120%2887%2980111-X

7 January 2021

Masking by enzyme inhibitor of raised serum glutamate dehydrogenase activity in Reye's syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9120%2887%2980111-X

7 January 2021

Absence of diffusible inhibitor of glutamate dehydrogenase in the hepatocytes of Reye syndrome patients

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9120%2887%2980111-X

7 January 2021

Glutamate dehydrogenase in Reye's syndrome. Evidence for the presence of an altered enzyme in serum with increased susceptibility to inhibition by GTP

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9120%2887%2980111-X

7 January 2021

Quantitative evaluation of the extent of hepatic enzyme changes in Reye syndrome compared with normal liver or with non-Reye liver disorders: objective criteria for animal models

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9120%2887%2980111-X

7 January 2021

Serum ornithine carbamyl transferase activities in Reye's syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9120%2887%2980111-X

7 January 2021

Reye's syndrome and hyperaminoacidemia

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9120%2887%2980111-X

7 January 2021

Biochemical correlates of illness and recovery in Reye's syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9120%2887%2980111-X

7 January 2021

Ornithine carbamyl transferase in Reye's syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9120%2887%2980111-X

7 January 2021

Identification of long chain dicarboxylic acids in the serum of two patients with Reye's syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9120%2887%2980111-X

7 January 2021

Urinary dicarboxylic acids in Reye syndrome.

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9120%2887%2980111-X

7 January 2021

Short-chain fatty acids and encephalopathy of Reye's syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9120%2887%2980111-X

7 January 2021

Urinary organic acid profiles of Reye's syndrome patients

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9120%2887%2980111-X

7 January 2021

C6-C10-dicarboxylic aciduria: investigations of a patient with riboflavin responsive multiple acyl-CoA dehydrogenation defects

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9120%2887%2980111-X

7 January 2021

Identification of 5-hydroxyhexanoic acid in the urine of twin siblings with a Reye's-like syndrome associated with dicarboxylic aciduria and hypoglycaemia and with similarities to Jamaican vomiting sickness

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9120%2887%2980111-X

7 January 2021

Non-ketotic C6-C10-dicarboxylic aciduria: biochemical investigations of two cases

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9120%2887%2980111-X

7 January 2021

Suberylglycine excretion in the urine from a patient with dicarboxylic aciduria

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9120%2887%2980111-X

7 January 2021

Dicarboxylic aciduria: The response to fasting

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9120%2887%2980111-X

7 January 2021

Mass spectrometric identification of abnormal aromatic compounds in the urine of a child with Reye's like syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9120%2887%2980111-X

7 January 2021

Liver coenzyme A ester content: comparison between Reye's syndrome and control subjects

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9120%2887%2980111-X

7 January 2021

Carnitine deficiency, organic acidemias, and Reye's syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9120%2887%2980111-X

7 January 2021

Identifiers

10.1016/S0009-9120(87)80111-X

1 reference

Europe PubMed Central

PubMed publication ID

13 September 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

13 September 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q39662146&oldid=1851973279"